Not Tagged
Not Tagged
['hodgkin', 'lymphoma']
at #asco2022: dr. , study chair, will give an oral presentation on novel therapeutics in a phase 3 trial for high-risk hodgkin lymphoma via in collaboration with frank keller, md, study vice chair, and . 
@ChildrensATL provides leading-edge care to kids who need it most. Alongside academic partner @EmoryUniversity, research translates into lifesaving treatments.